Sun Pharma Advanced Research Company informs about press release

26 Nov 2018 Evaluate

Pursuant to regulation 30 of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015, Sun Pharma Advanced Research Company has informed about submission of the Press Release titled,   ’SPARC announces Top-line Results of Pivotal Bioequivalence Study for Paclitaxel Injection Concentrate for Suspension being released by the company’, which is self-explanatory.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Adv. Res Share Price

134.60 0.15 (0.11%)
31-Dec-2025 11:43 View Price Chart
Peers
Company Name CMP
Syngene Internation. 650.85
Indegene 520.00
CMS Info Systems 339.20
Sagility 52.28
Smartworks Coworking 471.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×